Ken Griffin
TIL icon

Ken Griffin’s Instil Bio TIL Stock Holding History

Ken Griffin’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Sell
38,562
-8,773
-19% -$71.2K ﹤0.01% 10347
2025
Q4 		$521K Buy
+47,335
New +$700K ﹤0.01% 8938
2024
Q2 		– Sell
-15,438
Closed -$167K – 15402
2024
Q1 		$167K Sell
15,438
-12,860
-45% -$141K ﹤0.01% 10606
2023
Q4 		$216K Buy
28,298
+25,966
+1,113% +$188K ﹤0.01% 9801
2023
Q3 		$20K Sell
2,332
-7,957
-77% -$80.2K ﹤0.01% 12629
2023
Q2 		$113K Buy
10,289
+3,427
+50% +$41.9K ﹤0.01% 10735
2023
Q1 		$90.7K Sell
6,862
-16,838
-71% -$249K ﹤0.01% 11404
2022
Q4 		$299K Buy
23,700
+9,351
+65% +$462K ﹤0.01% 9332
2022
Q3 		$1.39M Sell
14,349
-3,158
-18% -$361K ﹤0.01% 6310
2022
Q2 		$1.62M Buy
17,507
+6,455
+58% +$914K ﹤0.01% 5996
2022
Q1 		$2.38M Buy
+11,052
New +$2.58M ﹤0.01% 5710
2021
Q3 		– Sell
-2,799
Closed -$1.08M – 14651
2021
Q2 		$1.08M Sell
2,799
-64
-2% -$23.7K ﹤0.01% 8174
2021
Q1 		$1.44M Buy
+2,863
New +$1.47M ﹤0.01% 7214

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Ken Griffin's TIL Position: Q1 2026 in Review

Ken Griffin reduced its Instil Bio (TIL) stake by 19% in Q1 2026, selling an estimated $71.2K and leaving 38,562 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #10347.

Ken Griffin first reported a position in TIL in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.38M in Q1 2022. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Ken Griffin held 38,562 shares of Instil Bio worth $318K as of Q1 2026.
  • Ken Griffin sold 8,773 Instil Bio shares in Q1 2026, an estimated $71.2K.
  • Instil Bio made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #10347 holding.
  • Ken Griffin first reported a position in Instil Bio in Q1 2021 and has held it in 13 quarters since.
  • Ken Griffin's Instil Bio position peaked at $2.38M in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.